Clinical trial registry record

Pomegranate Extract and Inflammageing

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated January 20, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05588479
Last registry update
January 20, 2025
Status
Completed
Phase
Phase not reported
Sponsor
Manchester Metropolitan University
Enrollment
86
Countries
United Kingdom
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · DOUBLE
Evidence population
Human clinical study registration
Participants
86
Population
ALL · 55 Years to 70 Years
Duration
2022-12-10 to 2024-06-30
Intervention
Pomegranate extract; Control
Comparator
Control
Outcomes measured
Interleukin-6 (IL-6) levels — Baseline, week 6 & week 12; CRP (C-reactive protein) levels — Baseline, week 6 & week 12; Interleukin 1 (IL-1) levels — Baseline, week 6 & week 12; Interleukin 2 (IL-2) levels — Baseline, week 6 & week 12; Insulin growth factor-1 (IGF-1) levels — Baseline, week 6 & week 12; Tumour necrosis factor (TNF-α) levels — Baseline, week 6 & week 12; Plasminogen Activator Inhibitor-1 (PAI-1) levels — Baseline, week 6 & week 12; Telomerase activity — Baseline, week 6 & week 12; Corsi block-tapping test — Baseline, week 6 & week 12; Rey Verbal Learning test — Baseline, week 6 & week 12; Tower of Hanoi test — Baseline, week 6 & week 12; Wisconsin test — Baseline, week 6 & week 12; Stroop test — Baseline, week 6 & week 12; Digits span test — Baseline, week 6 & week 12; Hand grip strength — Baseline, week 6 & week 12; Standing balance — Baseline, week 6 & week 12; Gait speed — Baseline, week 6 & week 12; Chair sit to stand — Baseline, week 6 & week 12; Fasting serum glucose levels — Baseline, week 6 & week 12; Fasting lipid levels — Baseline, week 6 & week 12
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Chronic inflammation · 80%Title contains controlled term: inflammageing. Title supplies longevity context: ageing. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

chronic inflammation
Open primary sourceExport JSON